NCT06824207View on ClinicalTrials.gov

Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

Active, not recruitingOBSERVATIONAL

Enrollment

2,400

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2026

Conditions

Respiratory Syncytial Virus Immunization

Trial Locations (1)

Unknown

Germany

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY